Clinical Trials on Rotavirus Vaccines in France

Total 49 results

Pfizer

Completed

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Vaccines, Pneumococcal Conjugate Vaccine

United States, Spain, France, Canada, Germany, Czechia, Sweden, Belgium, Poland, Netherlands
University Hospital, Brest
MCM Vaccines B.V.

Completed

Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. (IVANHOE)

Rotavirus Gastroenteritis

France
Association Clinique Thérapeutique Infantile du...
Pfizer

Recruiting

National Bacterial Meningitis Study

Meningitis | Children, Only | Neonatal Infection | Meningococcal Vaccines | Pneumococcal Conjugate Vaccine | Antibiotic Treatment | H. Influenzae Vaccine | Case Fatality Rate

France
Centre National de la Recherche Scientifique, France
Université Paris-Dauphine; Fondation La main à la pâte; Direction de l Évaluation...

Completed

Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents (Kidivax)

Health Knowledge, Attitudes, Practice | Vaccine Hesitancy | Vaccine Refusal

France
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
GlaxoSmithKline

Completed

To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

Infections, Rotavirus

Spain, Poland, France, Portugal
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
GlaxoSmithKline

Completed

Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus

United States, Taiwan, Canada, Hong Kong, Turkey
Centre Hospitalier René Dubos

Completed

Pneumococcal Vaccination in Patients With Anti-TNF Alpha Therapy (TNF-VAX)

Pneumococcal Vaccine

France
University Hospital, Grenoble

Unknown

Difference Between Patient Vaccine Hesitancy and Perception by Their Family Physician of Their Vaccine Hesitancy (DiffHésiVac)

Vaccine Hesitancy

France
Institut National de la Santé Et de la Recherche...

Completed

Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability (PrevHPV)

HPV Vaccine Acceptability

France
Assistance Publique - Hôpitaux de Paris
Innovative clinical research network in vaccinology (I-REIVAC); Observatoire...

Completed

Vaccine Attitudes and Practices of Hospital Specialists (SPECIVAC)

Vaccine Practice

France
Hospices Civils de Lyon

Completed

Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine (ROMANOV)

Hemodialysis Complication | COVID-19 Vaccines

France
Assistance Publique - Hôpitaux de Paris

Completed

Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation (MENINGREF)

Hematopoietic Stem Cell Transplant | Meningococcal Vaccine

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

Vaccines, Pneumococcal

France
University Hospital, Brest

Completed

Impact of Catch-up HPV Vaccination (HPVAC2)

Cervical Cancer | Vaccine Preventable Disease | HPV | HPV Vaccination | Cervical Lesion

France
Centre Hospitalier Annecy Genevois
Hospices Civils de Lyon; Institut National de la Santé Et de la Recherche Médicale... and other collaborators

Completed

Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression (INFLUOMICS)

Vaccine Reaction

France
University Hospital, Caen

Completed

COVID-19 Vaccines Associated Malaise

Vaccine Adverse Reaction

France
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (GeniusVac-Mel4)

Melanoma | Effects of Immunotherapy | Tumor Vaccines

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease (MC-HPV)

Human Papillomavirus Vaccine | Chronic Condition

France
University Hospital, Strasbourg, France

Recruiting

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals (COVACHUS)

COVID-19 Vaccines

France
Pfizer

Completed

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Safety | Immunization | 13-valent Pneumococcal Vaccine | Antibody Response

France
Assistance Publique - Hôpitaux de Paris
IREIVAC/COVIREIVAC Network

Active, not recruiting

Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults (COVIBOOSTAnci1)

COVID-19 Vaccines

France
Association Clinique Thérapeutique Infantile du...
Pfizer

Recruiting

Invasive Pneumococcal Disease Study

Mortality | Pneumococcal Infections | Pneumococcal Conjugate Vaccine | Antibiotic Treatment

France
Calmy Alexandra

Recruiting

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls (Shingr'HIV)

RZV Vaccine (Shingrix ®)

Switzerland, France
Assistance Publique - Hôpitaux de Paris

Recruiting

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies (COVIDVAC OH)

Solid Tumor | Thoracic Cancer | Hematologic Malignancy | Cancer, Treatment-Related | Vaccine Response Impaired

France
University Hospital, Lille

Active, not recruiting

Covid-19 Vaccine Response in Elderly Subjects (MONITOCOVAGING)

Covid19 Vaccine

France
Assistance Publique - Hôpitaux de Paris
IREIVAC/COVIREIVAC Network

Active, not recruiting

Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine (CoviBOOST 2)

COVID-19 | Vaccine Reaction

France
Assistance Publique - Hôpitaux de Paris
COVIREIVAC

Active, not recruiting

Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination (COVIBOOST)

COVID-19 | Vaccine Reaction

France
Pfizer

Terminated

Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation (STRIVE)

Staphylococcal Vaccine

United States, Spain, United Kingdom, Canada, France, Japan, Germany, Hungary, Austria, Bulgaria, Sweden
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety of Influenza Vaccine During Sarcoidosis (SARCOVAC)

Influenza Vaccine | Sarcoidosis

France
University Hospital, Clermont-Ferrand

Recruiting

Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff (COVIDIM)

Hospital Staff | Vaccined Againt COVID-19

France
GlaxoSmithKline

Completed

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Infections, Meningococcal | Meningococcal Vaccines

Germany, France
Assistance Publique - Hôpitaux de Paris

Completed

Covid-19 Vaccine Response in Heart Transplant Recipients (COVHEART)

Heart Transplantation | COVID-19 Vaccine | COVID-19 Virus Infection

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Allergy and COVID-19 Vaccines (COVALL)

Vaccine Reaction | Anaphylactic Reaction

France
Groupe d'Etude sur le Risque d'Exposition des Soignants...
Agence Regionale de Sante d'Ile de France; National Agency of Public Health

Completed

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region (GriCoVax)

Pregnant Women | Influenza Vaccination | Pertussis Vaccine | Healthcare Worker Patient Transmission

France
Centre Hospitalier de Cornouaille

Completed

Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients (HEMVACO)

Covid19 | Hematologic Malignancy | Vaccine Response Impaired

France
Assistance Publique - Hôpitaux de Paris
COVIREIVAC

Active, not recruiting

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine (ARNCOMBI)

Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose

France
Central Hospital, Nancy, France

Unknown

Influenza Vaccine in Children With Asthma (VAGA)

Asthma in Children | Influenza Vaccine | Immunization Coverage

France
University Hospital, Caen

Completed

Transverse Myelitis Related to SARS-CoV-2 Vaccines

Vaccine Adverse Reaction

France
FluGen Inc
United States Department of Defense

Completed

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Influenza Vaccine

United States
Pfizer

Completed

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease

Pneumococcal Conjugate Vaccine

France, United States, United Kingdom, Lebanon, Italy, Egypt, Saudi Arabia
Poitiers University Hospital

Recruiting

Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma (HEMATOVAC)

Lymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Vaccine | Streptococcus Pneumoniae

France
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

Herpes Zoster | Herpes Zoster Vaccine

Canada, Spain, Korea, Republic of, United Kingdom, France, Czechia
Jennerex Biotherapeutics

Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (TRAVERSE)

HCC | Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
GlaxoSmithKline

Completed

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Infections, Papillomavirus | Papillomavirus Vaccines

Thailand, Estonia, India, Brazil
Jennerex Biotherapeutics
Transgene

Completed

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Colorectal Carcinoma | CRC

Canada, United States, France
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
SillaJen, Inc.

Completed

Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone (PHOCUS)

Hepatocellular Carcinoma (HCC)

United States, Canada, New Zealand, Australia, China, France, Germany, Hong Kong, Israel, Italy, Korea, Republic of, Portugal, Singapore, Taiwan, Thailand, United Kingdom

Clinical Trials on Rotavirus Vaccines in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations